berotek and am 251
berotek has been researched along with am 251 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bernier, M; Gonzalez-Mariscal, I; Indig, FE; Moaddel, R; Nayak, SK; Pajak, K; Paul, RK; Wainer, IW; Wnorowski, A | 1 |
Other Studies
1 other study(ies) available for berotek and am 251
| Article | Year |
|---|---|
(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.
Topics: Cell Movement; Drug Inverse Agonism; Endocytosis; Fenoterol; HEK293 Cells; Hep G2 Cells; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, G-Protein-Coupled | 2014 |